May 9, 2024
Evaluation of Keytruda Combined with Chemotherapy as Post-Surgical Treatment in Newly Diagnosed Endometrial Cancer Shows Limited Efficacy
Keytruda, Merck, endometrial cancer, post-surgical therapy, newly diagnosed, chemotherapy, clinical trial, limited efficacy.
Revolutionizing Cardiac Mapping: J&J’s Biosense Webster Integrates AI into Carto 3 System
J&J, Biosense Webster, AI, Carto 3 system, cardiac mapping, heart mapping, electrophysiology, medical technology, healthcare innovation.
Innovent Scores Phase 3 Success with Lilly’s Pioneering Obesity Drug for Diabetes Management
Innovent Biologics, Eli Lilly, obesity drug, diabetes management, phase 3 trials, collaboration, metabolic disorders, weight loss, glucose control, next-generation therapy.
Attovia Secures $105M for Multiple Trials of Innovative Industrial and Institutional Biologics
Attovia, biologics, industrial and institutional (I&I), crossover investors, funding, clinical trials
Marinus Pharmaceuticals Reduces Workforce Amidst Challenges in Epilepsy Treatment Development
Marinus Pharmaceuticals, workforce reduction, epilepsy treatment, clinical trials, financial restructuring
Sanofi’s Chief Scientific Officer Frank Nestle Announces Departure
Sanofi, Frank Nestle, Chief Scientific Officer, resignation, pharmaceutical industry, leadership change.
Pioneering Gene Therapy Restores Hearing in Children with Otoferlin-Linked Deafness
Gene therapy, otoferlin-related deafness, hearing restoration, children, genetic mutation, clinical trial, auditory function.